Concepedia

Lotte Vinge

LV

Statistics

Publications

11

Citations

1.2K

H-Index

11

Active since

2013

Affiliations

Aarhus University Hospital(Current)

Alexion Pharmaceuticals (United States)

Fondazione IRCCS Istituto Neurologico Carlo Besta

University of Copenhagen

University of North Carolina at Chapel Hill

Lotte Vinge is an author at Aarhus University Hospital specializing in medicine, myasthenia gravis, and myasthenia gravis pharmacotherapy.

Publications per year

2013–2021

11

Publications

11

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

, , +6

Exercise in myasthenia gravis: A feasibility study of aerobic and resistance training

Martin Amadeus Rahbek, Erik Elgaard Mikkelsen, Kristian Overgaard et al. · Muscle & Nerve · 2017 · 90 citations

, , +17

Late-onset Pompe disease is prevalent in unclassified limb-girdle muscular dystrophies

Nicolai Preisler, Zoltán Lukács, Lotte Vinge et al. · Molecular Genetics and Metabolism · 2013 · 87 citations

, , +10

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 79 citations · Full text

, , +9

Eculizumab improves fatigue in refractory generalized myasthenia gravis

Henning Andersen, Renato Mantegazza, Jing Jing Wang et al. · Quality of Life Research · 2019 · 56 citations · Full text

, , +14

1–5 of 11